跳至主要内容
临床试验/NCT03471481
NCT03471481终止不适用

Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy

Drexel University2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2015年8月10日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
7
试验地点
2
主要终点
Bone mineral density

研究概览

简要总结

The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals receiving anti-epileptic drugs as a treatment for epilepsy

排除标准

  • Individuals who are pregnant or breastfeeding, receiving cancer treatments, have liver or kidney diseases, autoimmune diseases, or other diseases that may interfere with vitamin D and magnesium metabolism.

结局指标

主要结局

Bone mineral density

时间窗: 1 time point - baseline

Will be measured at Tibia, Hip and Total Body using a DXA scan

次要结局

  • Vitamin D - 25 hydroxy vitamin D(1 time point - baseline)
  • Ionized Magnesium in serum(1 time point - baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验